NovoCure NVCR Other international markets — Net revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's other international markets — net revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's other international markets — net revenues?
- NovoCure (NVCR) reported other international markets — net revenues of $15.68M in Q1 2026.
- How has NovoCure's other international markets — net revenues changed year-over-year?
- NovoCure's other international markets — net revenues increased by 31.3% year-over-year, from $11.94M to $15.68M.
- What is the long-term trend for NovoCure's other international markets — net revenues?
- Over 4 years (2021 to 2025), NovoCure's other international markets — net revenues has grown at a 16.8% compound annual growth rate (CAGR), from $30.58M to $56.9M.
- What does other international markets — net revenues mean?
- This metric represents the total net revenue generated from the sale of medical devices and associated services within geographic regions outside of the company's primary domestic and major international markets. It reflects the company's ability to expand its commercial footprint and capture market share in emerging or secondary global territories. Monitoring this revenue stream helps investors assess the effectiveness of the company's international commercialization strategy and its success in navigating diverse regulatory and healthcare reimbursement landscapes.